Elite Pharmaceuticals, Inc. (ELTP)

OTCMKTS · Delayed Price · Currency is USD
0.550
-0.020 (-3.51%)
Dec 20, 2024, 4:00 PM EST
290.90%
Market Cap 587.18M
Revenue (ttm) 71.17M
Net Income (ttm) -6.39M
Shares Out 1.07B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 755,900
Open 0.570
Previous Close 0.570
Day's Range 0.540 - 0.580
52-Week Range 0.120 - 0.750
Beta 0.18
Analysts n/a
Price Target n/a
Earnings Date Feb 13, 2025

About Elite Pharmaceuticals

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates through Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals segments. It owns, licenses, manufactures, and sells various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for the treatment of bariatrics under Adipex-P ... [Read more]

Sector Healthcare
Founded 1997
Employees 64
Stock Exchange OTCMKTS
Ticker Symbol ELTP
Full Company Profile

Financial Performance

In 2023, Elite Pharmaceuticals's revenue was $56.63 million, an increase of 65.79% compared to the previous year's $34.16 million. Earnings were $20.11 million, an increase of 464.56%.

Financial Statements

News

Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets

Northvale, New Jersey--(Newsfile Corp. - December 2, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,...

20 days ago - Newsfile Corp

Elite Pharmaceuticals Inc (ELTP) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Elite Pharmaceuticals Inc (ELTP) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Product Pipeline Expansion

4 weeks ago - GuruFocus

Q2 2025 Elite Pharmaceuticals Inc Earnings Call Transcript

Q2 2025 Elite Pharmaceuticals Inc Earnings Call Transcript

4 weeks ago - GuruFocus

Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse

Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manuf...

4 weeks ago - Newsfile Corp

Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call Transcript

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2025 Earnings Conference Call November 15, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO Conference Call Particip...

5 weeks ago - Seeking Alpha

Elite Pharmaceuticals Inc Reports $18.9 Million Revenue and $3. ...

Elite Pharmaceuticals Inc Reports $18.9 Million Revenue and $3.5 Million Operating Profit for Q2 FY2025

5 weeks ago - GuruFocus

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information

Conference Call Scheduled for Friday, November 15 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - November 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a ...

5 weeks ago - Newsfile Corp

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024

Financials for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 will be released on Thursday, November 14, 2024 Northvale, New Jersey--(Newsfile Corp. - November 7, 2024) - Elite Pharma...

6 weeks ago - Newsfile Corp

Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health

Northvale, New Jersey--(Newsfile Corp. - October 10, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,...

2 months ago - Newsfile Corp

Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets

Northvale, New Jersey--(Newsfile Corp. - October 7, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, ...

2 months ago - Newsfile Corp

Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium

Northvale, New Jersey--(Newsfile Corp. - August 27, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, ...

4 months ago - Newsfile Corp

Elite Pharmaceuticals, Inc. (ELTP) Q1 2025 Earnings Call Transcript

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q1 2025 Earnings Conference Call August 15, 2024 11:30 AM ET Company Participants Nasrat Hakim – President and Chief Executive Officer Carter Ward – Chief Fina...

4 months ago - Seeking Alpha

Elite Pharmaceuticals reports Q1 results

Elite Pharmaceuticals press release (ELTP): Q1 Revenue of $18.8M, an increase of $9.8 million or approximately 109% as compared to the comparable period of the prior fiscal year.

4 months ago - Seeking Alpha

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information

Conference Call Scheduled for Thursday, August 15 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - August 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a sp...

4 months ago - Newsfile Corp

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024

Financials for First Quarter of Fiscal Year 2025 Ended June 30, 2024 will be released on August 14, 2024 Northvale, New Jersey--(Newsfile Corp. - August 9, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ...

4 months ago - Newsfile Corp

Elite Pharmaceuticals, Inc. (ELTP) Q4 2024 Earnings Call Transcript

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2024 Earnings Conference Call July 2, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO, Secretary and Treasurer Conf...

6 months ago - Seeking Alpha

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, July 2 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - July 1, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

6 months ago - Newsfile Corp

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024

Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or th...

6 months ago - Newsfile Corp

Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate

NORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced t...

7 months ago - Accesswire

Elite Pharmaceuticals, Inc. (ELTP) Q3 2024 Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q3 2024 Earnings Call Transcript

11 months ago - Seeking Alpha

Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information

Conference Call Scheduled for Thursday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCBB:ELTP), a specialty pha...

11 months ago - Accesswire

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024

Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024 NORTHVALE, NJ / ACCESSWIRE / February 8, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the ...

11 months ago - Accesswire

Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant

NORTHVALE, NJ / ACCESSWIRE / December 26, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and di...

1 year ago - Accesswire

Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC

NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announ...

1 year ago - Accesswire